USD 1.13
(-13.08%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Operating Cash Flow | -1.68 Million | -1.79 Million | -269.51 Thousand | -115.62 Thousand |
Net Income | -4 Million | -1.06 Million | -394.33 Thousand | -1.62 Million |
Depreciation & Amortization | 354.00 | 527.00 | 768.62 | 451.71 |
Deferred income taxes | 155.00 | - | - | 2.12 |
Stock-based compensation | 481.39 Thousand | 162.62 Thousand | - | 1.41 Million |
Change in working capital | 64.9 Thousand | -199.78 Thousand | 21.28 Thousand | 23.54 Thousand |
Other non-cash items | 1.76 Million | -686.78 Thousand | 102.76 Thousand | 66.46 Thousand |
Investing Cash Flow | 1.96 Million | -12.51 Million | -541.55 Thousand | -855.92 Thousand |
Investments in PPE | -1.56 Million | -1.06 Million | -579.53 Thousand | -463.81 Thousand |
Acquisitions | 1.56 Million | - | - | - |
Investment purchases | -13.5 Million | -14 Million | - | -392.1 Thousand |
Sales/Maturities of investments | 16.5 Million | 2.5 Million | 37.97 Thousand | - |
Other Investing Activities | -1.03 Million | 49.15 Thousand | 0.80 | -750.00 |
Financing Cash Flow | - | 13.85 Million | -22.52 | 2.87 Million |
Debt repayment | - | - | - | - |
Dividends payments | - | - | - | - |
Common Stock Repurchased | - | - | - | - |
Common Stock Issuance | - | 15.01 Million | - | 2.87 Million |
Other Financing Activities | - | -1.16 Million | - | 5491.01 |
Accounts receivables | 20.49 Thousand | -207.21 Thousand | -6617.84 | -2335.79 |
Accounts payables | - | 31.28 Thousand | - | - |
Inventory | - | 207.21 Thousand | - | - |
Other working capital | 44.41 Thousand | -231.07 Thousand | 27.9 Thousand | 25.88 Thousand |
Cash at beginning of period | 630.62 Thousand | 1.09 Million | 1.89 Million | - |
Cash at end of period | 907.55 Thousand | 630.62 Thousand | 1.08 Million | 1.89 Million |
Capital Expenditure | -1.56 Million | -1.06 Million | -579.53 Thousand | -463.81 Thousand |
Effect of forex changes on cash | 1963.00 | -8260.00 | 22.01 | -0.25 |
Net cash flow / Change in cash | 276.92 Thousand | -463.92 Thousand | -811.06 Thousand | 1.89 Million |
Free Cash Flow | -3.24 Million | -2.85 Million | -849.04 Thousand | -579.43 Thousand |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -615.12 Thousand | -775.66 Thousand | -4 Million | -1.7 Million | -292.11 Thousand | -1.51 Million |
Depreciation & Amortization | 612.00 | 246.00 | 354.00 | 88.00 | 89.00 | 89.00 |
Deferred income taxes | - | 150.00 | 155.00 | -270.73 Thousand | 1429.00 | 155.00 |
Stock-based compensation | 210.88 Thousand | 354.47 Thousand | 481.39 Thousand | 301.63 Thousand | 39.87 Thousand | 53.88 Thousand |
Change in working capital | -243.66 Thousand | 132.16 Thousand | 64.9 Thousand | 72.1 Thousand | 58.14 Thousand | -351.62 Thousand |
Other non-cash items | 371.99 Thousand | 202.36 Thousand | 1.76 Million | 1.3 Million | -130.06 Thousand | 1.09 Million |
Investing Cash Flow | -26.36 Thousand | 1.3 Million | 1.96 Million | -1.97 Million | 1.84 Million | -1.51 Million |
Investments in PPE | -756.9 Thousand | -695.45 Thousand | -1.56 Million | -431.88 Thousand | -818.27 Thousand | -85.67 Thousand |
Acquisitions | - | - | 1.56 Million | 1830.11 | 818.27 Thousand | -35.34 Thousand |
Investment purchases | -730.53 Thousand | -2 Million | -13.5 Million | -1.32 Million | -4 Million | -1.5 Million |
Sales/Maturities of investments | 1.46 Million | 4 Million | 16.5 Million | -218.7 Thousand | 6.5 Million | 35.34 Thousand |
Other Investing Activities | -687.8 Thousand | 2821.52 | -1.03 Million | -1830.11 | -656.26 Thousand | 72.16 Thousand |
Financing Cash Flow | - | - | - | 13.14 Thousand | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | -175.66 Thousand | 126.77 Thousand | 20.49 Thousand | 31.07 Thousand | 79.64 Thousand | -260.57 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -67.99 Thousand | 5393.00 | 44.41 Thousand | 41.03 Thousand | -21.49 Thousand | -91.05 Thousand |
Cash at beginning of period | 1.89 Million | 907.55 Thousand | 630.62 Thousand | 3.16 Million | 1.64 Million | 3.87 Million |
Cash at end of period | 1.2 Million | 1.89 Million | 907.55 Thousand | 907.55 Thousand | 3.16 Million | 1.64 Million |
Capital Expenditure | -756.9 Thousand | -695.45 Thousand | -1.56 Million | -431.88 Thousand | -818.27 Thousand | -85.67 Thousand |
Effect of forex changes on cash | -379.00 | -1869.00 | 1963.00 | 1856.00 | -1246.00 | 1187.00 |
Net cash flow / Change in cash | -687.67 Thousand | 988.06 Thousand | 276.92 Thousand | -2.25 Million | 1.51 Million | -2.23 Million |
Free Cash Flow | -1.41 Million | -1.01 Million | -3.24 Million | -725.56 Thousand | -1.14 Million | -806.9 Thousand |
AMAT
SJVN
MEEC
GUFICBIO
002790
LSPK